Literature DB >> 20979997

A novel method of luteal supplementation with recombinant luteinizing hormone when a gonadotropin-releasing hormone agonist is used instead of human chorionic gonadotropin for ovulation triggering: a randomized prospective proof of concept study.

Evangelos G Papanikolaou1, Willem Verpoest, Human Fatemi, Basil Tarlatzis, Paul Devroey, Herman Tournaye.   

Abstract

This pilot study investigates the role of luteal supplementation with recombinant LH in an attempt to reverse the poor reproductive outcome previously noticed after GnRH-agonist triggering of final oocyte maturation for IVF. Similar implantation rates were achieved with the novel recombinant LH luteal supplementation scheme compared with the standard luteal P protocol (25.0% vs. 26.7%, respectively). No cases of ovarian hyperstimulation syndrome (OHSS) were noticed in either group.
Copyright © 2011 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20979997     DOI： 10.1016/j.fertnstert.2010.09.023

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  22 in total

1.  Micro-dose hCG as luteal phase support without exogenous progesterone administration: mathematical modelling of the hCG concentration in circulation and initial clinical experience.

Authors:  C Yding Andersen; R Fischer; V Giorgione; Thomas W Kelsey
Journal:  J Assist Reprod Genet       Date:  2016-07-22       Impact factor: 3.412

Review 2.  Luteal phase support for assisted reproduction cycles.

Authors:  Michelle van der Linden; Karen Buckingham; Cindy Farquhar; Jan A M Kremer; Mostafa Metwally
Journal:  Cochrane Database Syst Rev       Date:  2015-07-07

3.  Comparison of two different dosage of GnRH agonist as ovulation trigger in oocyte donors: a randomized controled trial.

Authors:  Sonia Morales Zarcos; Pamela Valdivieso Mejía; Carla Donado Stefani; Pascual Sánchez Martin; Fernando Sánchez Martin
Journal:  JBRA Assist Reprod       Date:  2017-09-01

4.  An update on the prevention of ovarian hyperstimulation syndrome.

Authors:  Omar El Tokhy; Julia Kopeika; Tarek El-Toukhy
Journal:  Womens Health (Lond)       Date:  2016-08-19

5.  New algorithm for OHSS prevention.

Authors:  Evangelos G Papanikolaou; Peter Humaidan; Nikos Polyzos; Sofia Kalantaridou; Sahar Kol; Claudio Benadiva; Herman Tournaye; Basil Tarlatzis
Journal:  Reprod Biol Endocrinol       Date:  2011-11-03       Impact factor: 5.211

Review 6.  GnRH agonist for final oocyte maturation in GnRH antagonist co-treated IVF/ICSI treatment cycles: Systematic review and meta-analysis.

Authors:  M A F Youssef; Hatem I Abdelmoty; Mohamed A S Ahmed; Maged Elmohamady
Journal:  J Adv Res       Date:  2015-01-21       Impact factor: 10.479

7.  Contribution to More Patient-Friendly ART Treatment: Efficacy of Continuous Low-Dose GnRH Agonist as the Only Luteal Support-Results of a Prospective, Randomized, Comparative Study.

Authors:  Céline Pirard; Ernest Loumaye; Pascale Laurent; Christine Wyns
Journal:  Int J Endocrinol       Date:  2015-04-05       Impact factor: 3.257

Review 8.  Pharmaceutical options for triggering of final oocyte maturation in ART.

Authors:  Juan Carlos Castillo; Peter Humaidan; Rafael Bernabéu
Journal:  Biomed Res Int       Date:  2014-07-15       Impact factor: 3.411

Review 9.  Gonadotrophins: The future.

Authors:  Madhuri Patil
Journal:  J Hum Reprod Sci       Date:  2014 Oct-Dec

10.  Morphological changes of gonadotropin-releasing hormone neurons in the rat preoptic area across puberty.

Authors:  Haogang Xue; Xiaodong Gai; Weiqi Sun; Chun Li; Quan Liu
Journal:  Neural Regen Res       Date:  2014-07-01       Impact factor: 5.135
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.